PharmTech News

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Articles

The updated guidelines detail best practices for conducting research with human embryonic stem cells.

ISSCR Releases Updated Guidelines on Stem Cell Research

ANSM lifted the suspension on Catalent’s Beinheim, France facility, allowing the company to resume pharmaceutical operations.

Regulators Lift Suspension on Catalent Softgel Facility

The companies have agreed to an all-stock merger of equals transaction anticipated to close in the second half of 2016.

IMS Health Holdings and Quintiles to Combine

AbbVie will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T), a novel biomarker-specific therapy derived from cancer stem cells.

AbbVie to Acquire Stemcentrx

WHO report highlights goal of eliminating malaria in 35 countries by 2030.

WHO Releases Report on Eliminating Malaria

Pfizer announced the launch of Pfizer CentreOne, a CMO formed by the combination of Pfizer CentreSource and Hospira One 2 One.

Pfizer Launches Newly Combined CMO

The National Institutes of Health (NIH) released a statement on April 19, 2016 saying that it plans to suspend research in two laboratories after preliminary results found the labs not in compliance with CGMP practices.

NIH Suspends Research in Sterile Production Facilities

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.

NIH Study Identifies Better Parameter to Predict Flu Vaccine Effectiveness

The IMS Institute for Healthcare Informatics report examines spending on medicine in the US, drivers of growth, major market segments, prescription volume, patient costs, and healthcare delivery changes.

IMS Institute Report Examines Medicine Use and Spending in 2015

The conference will take place from May 16–18, 2017 in Philadelphia, Pennsylvania.

Top News